| Nimenrix (MenACWY-TT) / Pfizer |
NCT00196976: Safety & Immunogenicity of 1 Dose of GSK134612 in Children 12-14 Months and 3-5 Years Old |
|
|
| Completed | 2 | 461 | Europe | Conjugated meningococcal ACWY-TT (vaccine), DTPa-IPV/Hib vaccine (Infanrix™-IPV/Hib), DTPa-HBV-IPV/Hib vaccine (Infanrix hexa™), Meningitec™, Mencevax™ACWY | GlaxoSmithKline | Infections, Meningococcal | 03/06 | 03/06 | | |
NCT00126984: Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine |
|
|
| Completed | 2 | 508 | Europe | Conjugated meningococcal ACWY-TT (vaccine), DTPa/Hib containing vaccine, Meningitec, Mencevax ACWY | GlaxoSmithKline | Infections, Meningococcal | 02/08 | 02/08 | | |
NCT00661557: Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects |
|
|
| Completed | 2 | 271 | RoW | Meningococcal vaccine GSK134612 (Nimenrix) | GlaxoSmithKline | Infections, Meningococcal | 12/08 | 12/08 | | |
NCT01165242 / 2012-001305-25: Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine GSK 134612 Versus Menactra® in Healthy Adolescents/Adults |
|
|
| Completed | 2 | 1013 | US, Canada | Meningococcal vaccine GSK 134612, Menactra® | GlaxoSmithKline | Infections, Meningococcal | 02/11 | 07/11 | | |
NCT00715910 / 2012-002718-38: The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults |
|
|
| Completed | 2 | 818 | US | Nimenrix, Meningococcal vaccine GSK134612 (MenACWY-TT), Blood sampling | GlaxoSmithKline | Infections, Meningococcal | 04/13 | 10/13 | | |
NCT01994629 / 2013-000862-13: Safety and Immunogenicity of One Dose of Novartis' Meningococcal ACWY-CRM Vaccine and GlaxoSmithKline Biologicals' Meningococcal ACWY-TT Vaccine in Healthy Toddlers |
|
|
| Completed | 2 | 202 | Europe | MenACWY-CRM, MenACWY-TT | Novartis Vaccines | Meningococcal Disease | 04/14 | 10/14 | | |
NCT01782066: Dose-finding and Safety of 2 Intradermal MEN-ACYW135-conjugate Vaccines |
|
|
| Completed | 1/2 | 12 | Europe | MEN-ACYW135 reduced-dose intradermal administration, Menveo, Nimenrix | Leiden University Medical Center | Meningococcal Disease | 02/14 | 02/14 | | |
